Moleculin gets approval to amend protocol in early-stage annamycin leukemia study
July 13 2021 - 8:49AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
From Apr 2024 to May 2024
Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
From May 2023 to May 2024